ENDRA Life Sciences Future Growth
Future criteria checks 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for ENDRA Life Sciences.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
Medical Equipment earnings growth | 16.2% |
Revenue growth rate | n/a |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 21 Nov 2023 |
Recent future growth updates
Recent updates
ENDRA to submit FDA De Novo request for liver disease monitoring system in coming weeks
Sep 29ENDRA Life Sciences receives European patent for TAEUS system
Aug 24Endra Life Sciences Q2 2022 Earnings Preview
Aug 12We're A Little Worried About ENDRA Life Sciences' (NASDAQ:NDRA) Cash Burn Rate
Aug 08We're Keeping An Eye On ENDRA Life Sciences' (NASDAQ:NDRA) Cash Burn Rate
Nov 18We Think ENDRA Life Sciences (NASDAQ:NDRA) Needs To Drive Business Growth Carefully
Jul 19ENDRA Life Sciences names Irina Pestrikova Principal Financial Officer
Jun 15ENDRA Life Sciences granted 13th U.S. Patent for its TAEUS platform technology
Jan 13ENDRA Life Sciences renews GE Healthcare collaboration agreement
Dec 21Endra Life prices $5M-share offering
Dec 16Endra Life Sciences EPS beats by $0.02
Nov 16Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2024 | 1 | -12 | N/A | -10 | 1 |
12/31/2023 | N/A | -10 | -10 | -10 | N/A |
9/30/2023 | N/A | -12 | -11 | -10 | N/A |
6/30/2023 | N/A | -12 | -11 | -11 | N/A |
3/31/2023 | N/A | -13 | -12 | -12 | N/A |
12/31/2022 | N/A | -13 | -13 | -13 | N/A |
9/30/2022 | N/A | -13 | -12 | -12 | N/A |
6/30/2022 | N/A | -12 | -12 | -12 | N/A |
3/31/2022 | N/A | -12 | -11 | -11 | N/A |
12/31/2021 | N/A | -11 | -11 | -11 | N/A |
9/30/2021 | N/A | -10 | -11 | -11 | N/A |
6/30/2021 | N/A | -11 | -10 | -10 | N/A |
3/31/2021 | N/A | -11 | -11 | -11 | N/A |
12/31/2020 | N/A | -12 | -11 | -11 | N/A |
9/30/2020 | N/A | -19 | -11 | -11 | N/A |
6/30/2020 | N/A | -19 | -11 | -11 | N/A |
3/31/2020 | N/A | -18 | -9 | -9 | N/A |
12/31/2019 | N/A | -18 | -9 | -9 | N/A |
9/30/2019 | N/A | -11 | -9 | -9 | N/A |
6/30/2019 | N/A | -10 | -8 | -8 | N/A |
3/31/2019 | N/A | -10 | -8 | -8 | N/A |
12/31/2018 | 0 | -10 | -8 | -8 | N/A |
9/30/2018 | 0 | -10 | -7 | -7 | N/A |
6/30/2018 | 0 | -8 | -6 | -6 | N/A |
3/31/2018 | 0 | -7 | -6 | -6 | N/A |
12/31/2017 | 0 | -5 | -3 | -3 | N/A |
9/30/2017 | 1 | -4 | N/A | -2 | N/A |
6/30/2017 | 1 | -4 | N/A | -2 | N/A |
3/31/2017 | 1 | -3 | N/A | -1 | N/A |
12/31/2016 | 1 | -3 | N/A | -1 | N/A |
9/30/2016 | 0 | -3 | N/A | -1 | N/A |
6/30/2016 | 1 | -2 | N/A | -1 | N/A |
3/31/2016 | 1 | -2 | N/A | -1 | N/A |
12/31/2015 | 1 | -2 | N/A | -1 | N/A |
12/31/2014 | 1 | -2 | N/A | -1 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if NDRA's forecast earnings growth is above the savings rate (2.3%).
Earnings vs Market: Insufficient data to determine if NDRA's earnings are forecast to grow faster than the US market
High Growth Earnings: Insufficient data to determine if NDRA's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if NDRA's revenue is forecast to grow faster than the US market.
High Growth Revenue: Insufficient data to determine if NDRA's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if NDRA's Return on Equity is forecast to be high in 3 years time